Atlas Trials

To Evaluate the Safety, Tolerability, and Pharmacokinetics After Subcutaneous Administration of C1K in Healthy Subjects

Clinical trial NCT05980065 · COMPLETED

Trial details

NCT number
NCT05980065
Sponsor
Seoul National University Hospital
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Healthy Subjects
Start date
2022-12-20
Primary completion
2023-06-13
Enrollment
35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.